MA moves to revoke license of pharmacy linked to meningitis outbreak
Inspectors have finished the first stage of an investigation at the compounding pharmacy that produced the steroids linked to the fungal meningitis outbreak, New England Compounding Center in Framingham. The inspection paints a picture of a pharmacy poised for problems. One claim is that batches of the steroid linked to deaths across the country were shipped out before NECC pharmacists had even confirmed they were safe.
- Why Is Healthcare Price Transparency So Hard?
- Two-Midnights Rule Spells Grim Financial Forecast for Hospitals
- Researchers Link ICD-10 Shift to Financial Losses
- EHR Spending Continues, But Jury Still Out on ROI
- 5 Hot Healthcare Ideas from SXSW
- The Trouble with Hospital Price Transparency
- Hospital Groups Strike Back at Hospital Rating Systems
- 4 Marketing Tactics for Hospitals on Instagram
- Hospital CEO Turnover Hits Record High
- Adverse Events from Insulin Prescribing 'An Epidemic'